search
Back to results

Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

Primary Purpose

Pain Threshold, Mood

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Placebo capsules
Inactive marijuana (0% THC)
Low dose Dronabinol
High dose Dronabinol
Low THC marijuana
High THC marijuana
Sponsored by
New York State Psychiatric Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Pain Threshold focused on measuring oral thc, cannabis, pain, analgesic effects, dronabinol

Eligibility Criteria

21 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Adults between the ages of 21-45
  • Current marijuana use
  • Able to perform study procedures
  • Women practicing an effective form of birth control

Exclusion Criteria:

  • Female subjects who are currently pregnant or breastfeeding
  • Current,repeated illicit drug use other than marijuana
  • Presence of significant medical illness
  • History of heart disease
  • Request for drug treatment
  • Current parole or probation
  • Recent history of significant violent behavior

Sites / Locations

  • New York State Psychiatric Institute

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Placebo Comparator

Experimental

Experimental

Experimental

Experimental

Arm Label

Placebo + inactive marijuana (0% THC)

Dronabinol 10 mg + Marijuana (0% THC)

Dronabinol 20 mg + Marijuana (0% THC)

Placebo + Marijuana (1.98% THC)

Placebo + Marijuana (3.56% THC)

Arm Description

Participants received placebo capsules and smoked inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

Participants received low dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

Participants received High dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

Participants received placebo + low THC marijuana (1.98% THC) on 1 of 5 outpatient sessions in randomized order.

Participants received placebo + smoked high THC marijuana (3.56 % THC) on 1 of 5 outpatient sessions in randomized order.

Outcomes

Primary Outcome Measures

Pain Tolerance
Change in pain tolerance from baseline (in seconds) as a function of drug condition. The cold pressor test was administered during each session to examine changes in pain threshold (how many seconds it takes for a participant to begin feeling pain after cold water immersion).

Secondary Outcome Measures

Full Information

First Posted
August 26, 2008
Last Updated
November 7, 2017
Sponsor
New York State Psychiatric Institute
Collaborators
Research Foundation for Mental Hygiene, Inc., National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00743119
Brief Title
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
Official Title
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
June 2008 (undefined)
Primary Completion Date
October 2009 (Actual)
Study Completion Date
May 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
New York State Psychiatric Institute
Collaborators
Research Foundation for Mental Hygiene, Inc., National Institute on Drug Abuse (NIDA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The following study is designed to determine the analgesic efficacy of smoked marijuana (0, 1.98, and 3.56% THC) and oral THC (0, 10, and 20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Oral THC (dronabinol) is known to have a slower onset and longer duration of action compared with smoked marijuana. Therefore, the analgesic effects of oral THC is expected to peak later and last longer than effects produced by smoked marijuana.
Detailed Description
Laboratory animal studies have demonstrated the analgesic effects of drugs which act on the cannabinoid system, however, these effects have et to be clearly elucidated in humans. To better understand the potential clinical application of cannabinoids for pain management, the following study is designed to determine the analgesic efficacy of smoked marijuana (3.56% THC) and oral THC (20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Non-treatment seeking marijuana smokers will be recruited for a five-session study during which the analgesic, subjective, and physiologic effects of cannabinoids will be evaluated. Determining the efficacy of cannabinoids in an experimental model of pain will provide important endpoints (i.e., dose, route of administration, time course) or this effect to further investigate the potential role for clinical use of smoked marijuana and/or oral THC as analgesics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain Threshold, Mood
Keywords
oral thc, cannabis, pain, analgesic effects, dronabinol

7. Study Design

Primary Purpose
Other
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Masking Description
Placebo-controlled, double-blind
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo + inactive marijuana (0% THC)
Arm Type
Placebo Comparator
Arm Description
Participants received placebo capsules and smoked inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.
Arm Title
Dronabinol 10 mg + Marijuana (0% THC)
Arm Type
Experimental
Arm Description
Participants received low dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.
Arm Title
Dronabinol 20 mg + Marijuana (0% THC)
Arm Type
Experimental
Arm Description
Participants received High dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.
Arm Title
Placebo + Marijuana (1.98% THC)
Arm Type
Experimental
Arm Description
Participants received placebo + low THC marijuana (1.98% THC) on 1 of 5 outpatient sessions in randomized order.
Arm Title
Placebo + Marijuana (3.56% THC)
Arm Type
Experimental
Arm Description
Participants received placebo + smoked high THC marijuana (3.56 % THC) on 1 of 5 outpatient sessions in randomized order.
Intervention Type
Drug
Intervention Name(s)
Placebo capsules
Intervention Description
Placebo capsules
Intervention Type
Drug
Intervention Name(s)
Inactive marijuana (0% THC)
Intervention Description
Inactive marijuana cigarettes (0% THC) provided by NIDA
Intervention Type
Drug
Intervention Name(s)
Low dose Dronabinol
Intervention Description
Dronabinol 10mg
Intervention Type
Drug
Intervention Name(s)
High dose Dronabinol
Intervention Description
Dronabinol 20mg
Intervention Type
Drug
Intervention Name(s)
Low THC marijuana
Intervention Description
marijuana cigarettes (1.98% THC) provided by NIDA
Intervention Type
Drug
Intervention Name(s)
High THC marijuana
Intervention Description
Marijuana cigarettes (3.56% THC) provided by NIDA
Primary Outcome Measure Information:
Title
Pain Tolerance
Description
Change in pain tolerance from baseline (in seconds) as a function of drug condition. The cold pressor test was administered during each session to examine changes in pain threshold (how many seconds it takes for a participant to begin feeling pain after cold water immersion).
Time Frame
Within each session lasting approximately 5 minutes, for a total of five sessions

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adults between the ages of 21-45 Current marijuana use Able to perform study procedures Women practicing an effective form of birth control Exclusion Criteria: Female subjects who are currently pregnant or breastfeeding Current,repeated illicit drug use other than marijuana Presence of significant medical illness History of heart disease Request for drug treatment Current parole or probation Recent history of significant violent behavior
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret Haney, Ph.D
Organizational Affiliation
New York State Psychiatric Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York State Psychiatric Institute
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23609132
Citation
Cooper ZD, Comer SD, Haney M. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology. 2013 Sep;38(10):1984-92. doi: 10.1038/npp.2013.97. Epub 2013 Apr 22.
Results Reference
background

Learn more about this trial

Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

We'll reach out to this number within 24 hrs